CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

FDA Expedited Investigational New Drug (IND) Pilot Program

RegulatoryPositive
AI Analysis

Summary

The FDA announced the Expedited IND Pilot Program under HHS Operation TrialBlazer to evaluate new approaches for accelerating first-in-human clinical trials while maintaining safety and scientific oversight standards.

Importance:3/10
Sentiment:
0.30
FDAINDRegulatoryClinical TrialsFirst-in-Human

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on September 18, 2026 7:55 PM

Read Original